HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reflectance confocal microscopy allows in vivo real-time noninvasive assessment of the outcome of methyl aminolaevulinate photodynamic therapy of basal cell carcinoma.

AbstractBACKGROUND:
Photodynamic therapy (PDT) with methyl aminolaevulinate (MAL) is an approved noninvasive treatment option for basal cell carcinoma (BCC). In vivo reflectance confocal microscopy (RCM) is a noninvasive imaging technique that has proved useful for in vivo real-time cytomorphological analysis of BCC cells infiltrating the epidermis.
OBJECTIVES:
  To investigate the use of in vivo RCM to assess the persistence of BCC cells surviving MAL-PDT.
METHODS:
In vivo  RCM images of 20 biopsy-proven BCCs were taken before patients underwent a treatment cycle with MAL-PDT. Follow-up after 3months was performed using clinical examination, RCM and conventional dermoscopy. Treated areas also underwent a targeted 3-mm punch biopsy for standard haematoxylin and eosin histology stain to establish the clinical and instrumental correlation of the treatment outcome.
RESULTS:
  Three months after PDT, clinical examination established that two out of 20 BCCs were persistent; dermoscopy found three out of 20 residual BCCs, but RCM showed that one of these lesions was a false positive, and showed persistent BCC foci in five out of 20 lesions. Histological analysis of targeted biopsies confirmed these results.
CONCLUSIONS:
  RCM provided noninvasive, early detection of incipient recurrences of BCC after MAL-PDT. RCM findings steered targeted biopsies and surgical removal, or a new MAL-PDT, of these subclinical recurrences with minimal invasiveness.
AuthorsM Venturini, R Sala, S Gonzàlez, P G Calzavara-Pinton
JournalThe British journal of dermatology (Br J Dermatol) Vol. 168 Issue 1 Pg. 99-105 (Jan 2013) ISSN: 1365-2133 [Electronic] England
PMID23013443 (Publication Type: Journal Article)
Copyright© 2012 The Authors. BJD © 2012 British Association of Dermatologists.
Chemical References
  • Photosensitizing Agents
  • methyl 5-aminolevulinate
  • Aminolevulinic Acid
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Aminolevulinic Acid (analogs & derivatives, therapeutic use)
  • Carcinoma, Basal Cell (drug therapy, pathology)
  • Dermoscopy (methods)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Microscopy, Confocal (methods)
  • Middle Aged
  • Neoplasm Recurrence, Local (drug therapy, pathology)
  • Photochemotherapy (methods)
  • Photosensitizing Agents (therapeutic use)
  • Sensitivity and Specificity
  • Skin Neoplasms (drug therapy, pathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: